23
Participants
Start Date
May 31, 2012
Primary Completion Date
May 31, 2015
Study Completion Date
May 31, 2015
2-hydroxyflutamide (2-HOF)
Two components are mixed, transferred to a syringe and administered with injection into the prostate
Dept of Urology, University Hospital, Tampere
Dept of Urology, University Hospital, Uppsala
Lead Sponsor
Uppsala University
OTHER
Lidds AB
INDUSTRY